Pure Global
NCT06362863

Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease

A Randomized Controlled Study to Evaluate the Efficacy of Enteral Nutrition Biscuits in Inducing Remission in Moderate to Severe Crohn's Disease
Ping An·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Crohn's Disease
Drug/Device/Intervention
enteral nutrition biscuits
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Ping An
Funder
Renmin Hospital of Wuhan University
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Dec 01, 2025
Enrollment
52 participants
Primary outcome

Crohn's disease activity index, CDAI

Summary

By conducting a randomized controlled study of the role of enteral nutrition biscuits in the
 induction of remission in moderate-to-severe Crohn's disease, we will evaluate to investigate
 the role of enteral nutrition biscuits in the induction and remission phases of
 moderate-to-severe Crohn's disease; to assess patient adherence to enteral nutrition biscuits
 and the timing of their application; to assess the role of enteral nutrition biscuits in
 biologically refractory patients; and to assess the role of enteral nutrition biscuits in the
 remission of perianal, small bowel, and colonic lesions.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease [regional enteritis]Crohn disease of small intestine
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06362863
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06362863 through Pure Global AI's free database. This phase not specified trial is sponsored by Ping An and is currently Not yet recruiting. The study focuses on Crohn's Disease. Target enrollment is 52 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.